SECsense Logo

Co-Diagnostics, Inc. 8-K Report: Key Financial Insights as of February 21, 2025

$CODX
Form 8-K
Filed on: 2025-02-21
Source
Co-Diagnostics, Inc. 8-K Report: Key Financial Insights as of February 21, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Co-Diagnostics, Inc.
  • CIK Number: 0001692415
  • IRS Employer Identification Number: 46-2609363
  • Address: 2401 S. Foothill Drive Suite D, Salt Lake City, UT 84109
  • Contact Number: (801) 438-1036
  1. Filing Type:
  • Filing Date: February 21, 2025
  • Form Type: 8-K (Current Report)
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Ticker Symbol: CODX
  • Exchange: NASDAQ
  1. Financial Reporting Context:
  • Report Date: Financial data is reported as of February 21, 2025
  • Currency: All monetary values are reported in USD (United States Dollars).
  • Unit of Measure: The report includes measures in both USD and shares, indicating financial metrics might include per-share calculations.
  1. Period:
  • The reporting context indicates a single date (February 21, 2025), suggesting this may be a snapshot report rather than a full quarterly or annual report.
  1. Schema Reference:
  • The financial data is structured according to the XBRL (eXtensible Business Reporting Language) format, with a schema file referenced as "codx-20250221.xsd".

These elements provide a foundational overview of the company’s financial reporting status as of the specified date, along with critical identifiers and stock information. Further analysis could focus on the content of the 8-K filing for specific events or disclosures impacting the company.